Halozyme Reports Fourth Quarter and Full Year 2019 Results

Go back to Halozyme Reports Fourth Quarter and Full Year 2019 Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 109.66 +1.94 (1.80%)
Previous Close $107.72    52 Week High $18.39 
Open $105.84    52 Week Low $6.96 
Day High $109.76    P/E N/A 
Day Low $105.48    EPS $-0.58 
Volume 1,619,460